BeyondSpring downgraded by Jefferies with a new price target
$BYSI
Biotechnology: Pharmaceutical Preparations
Health Care
Jefferies downgraded BeyondSpring from Buy to Hold and set a new price target of $5.00 from $38.00 previously
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
12/2/2021 | $38.00 → $5.00 | Buy → Hold | Jefferies |
12/2/2021 | $45.00 → $5.00 | Buy → Underperform | B of A Securities |
12/1/2021 | Outperform → Mkt Perform | William Blair | |
12/1/2021 | Buy → Neutral | H.C. Wainwright | |
9/20/2021 | $100.00 → $65.00 | Buy | HC Wainwright & Co. |
9/9/2021 | $50.00 | Outperform | Robert W. Baird |
9/9/2021 | $50.00 | Outperform | Baird |
8/4/2021 | $100.00 | Neutral → Buy | HC Wainwright & Co. |
4 - BeyondSpring Inc. (0001677940) (Issuer)
4 - BeyondSpring Inc. (0001677940) (Issuer)
4 - BeyondSpring Inc. (0001677940) (Issuer)
Jefferies downgraded BeyondSpring from Buy to Hold and set a new price target of $5.00 from $38.00 previously
B of A Securities downgraded BeyondSpring from Buy to Underperform and set a new price target of $5.00 from $45.00 previously
William Blair downgraded BeyondSpring from Outperform to Mkt Perform